LEPREL2 has previously been identified, together with TGFBI, as part of a hub of genes controlling the response to 5-fluorouracil-based chemotherapy in colorectal cancer, although the level of expression of this gene was not itself significantly different between resistant and sensitive cell lines [60]. Here, TGFBI is linked to colorectal cancer.